Furthermore, treatment with the PPARγ agonist 15d-PGJ2 decreased autophagy-related protein expression and LC3 immunoreactivity in mice subjected to cerebral ischemia–reperfusion injury after MCAO [63]. Here, MAP1LC3A is linked to Cerebral ischemia.